Evaluates early recurrence in HCC patients after hepatectomy, suggesting a new nomogram for risk stratification.
Background/Aim: We evaluated the impact of log-transformed serum α-fetoprotein (AFP) and des-γ-carboxy prothrombin (DCP) levels on early hepatocellular carcinoma (HCC) recurrence after hepatectomy and developed a nomogram for risk stratification. Patients and Methods: We examined 993 patients who underwent initial curative hepatectomy. A nomogram was constructed to predict early recurrence within 2 years using a Cox proportional hazards model (five-factor log-marker model) based on five preoperatively assessable oncological factors: log AFP, log DCP, multiple tumors, tumor size >3 cm, and macroscopic vascular invasion (MVI). Its time-dependent area under the curve (AUC) at 2 years was compared with a five-factor raw-marker model (replacing log-transformed AFP/DCP with their raw values) and a three-factor model (multiple tumors, tumor size, MVI). Performance was evaluated by time-dependent AUC, bootstrap calibration (1,000 resamples), and observed outcomes across tertiles (T1-T3) of total nomogram points. Results: The five-factor log-marker model (AUC 0.69) outperformed the five-factor raw-marker model (0.67, p=0.013) and the three-factor model (0.65, p<0.001). The nomogram showed good calibration (slope=0.98). Two-year recurrence rates by tertile were 25% (T1), 38% (T2), and 58% (T3); 2-year extrahepatic recurrence rates were 1.5%, 4.2%, and 11%, respectively. The trend across tertiles was significant (p<0.001). Conclusion: The nomogram developed using preoperative oncological factors enabled precise prediction of early recurrence after hepatectomy for HCC by incorporating log-transformed AFP and DCP. Our nomogram may be useful in determining treatment strategies for patients with HCC.
No takes yet. Share an insight, caveat, or question.
Nakanishi et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: